Abstract:Yan-Hua Chen, 1 Xue-Luo Zhang, 1 Zhong-Yun Li, 2 Xian-Ping Wang, 1 Jun Wang, 3 Zhi-Ping Zhang, 1 Peng-Fei Zhu, 1 Xue-Qing Wu 1 1 Reproductive Medicine Center, Shanxi Maternal and Child Health Care Hospital, Taiyuan, People's Republic of China; 2 Rectum Branch, Shanxi Provincial Hospital of Traditional Chinese Medicine, Taiyuan, People's Republic of China; 3 The Sixth Hospital of Shanxi Medical University (General Hospital of Tisco), Taiyuan, People's Republic of China Correspondence: Xue-Qing Wu, Reproductive Medicine Center, Shanxi Maternal and Child Health Care Hospital, No. 13, Xinmin Middle Street, Xinghualing District, Taiyuan, Shanxi Province, 030013, People's Republic of China, Tel +86 351-3360725, Email Objective: This study aimed to evaluate the therapeutic efficacy and safety of Dan'e Fukang soft extracts in moderate ovarian hyperstimulation syndrome (OHSS) for the simultaneous treatment of blood and fluid, guided by the traditional Chinese medicine principle of "triple prevention". Methods: This study conducted a retrospective analysis of clinical data from outpatients who underwent in vitro fertilization (IVF)/intracytoplasmic sperm injection embryo transfer (ICSI-ET). A total of 2245 cases were included and divided into a treatment group (1002 cases) and a control group (1243 cases). Patients in the treatment group were administered Dan'e Fukang soft extracts orally in addition to conventional Western medicine. Comparative assessments were made between the two groups on pelvic ascites volume, maximum ovary diameter, dysmenorrhea incidence post-oocyte retrieval, and safety indicators. Results: There were no statistically significant differences between the treatment group and the control group in terms of general characteristics or the levels of follicle-stimulating hormone (FSH), luteotropic hormone (LH), estradiol (E2), or progesterone (P) at the time of gonadotropin (Gn) initiation. The groups did not differ significantly when we compared the levels of LH, E2, or P on the day of human chorionic gonadotropin (hCG) injection and during ovarian hyperstimulation protocols ( P > 0.05 for all indicators). The differences in the volume of pelvic ascites, the maximum ovarian diameter, and the incidence of dysmenorrhea after oocyte retrieval were statistically significant between the treatment group and the control group ( P < 0.05 in both). There were no instances of adverse reactions in either group. Conclusion: Based on the traditional Chinese medicine principle of "triple prevention", the use of Dan'e Fukang soft extracts for the simultaneous treatment of blood and fluid in moderate OHSS significantly improved the absorption of pelvic ascites, promoted ovarian recovery, and reduced the incidence of dysmenorrhea after oocyte retrieval. Keywords: Dan'e Fukang soft extracts, guiding principle of triple prevention, in vitro fertilization embryo transfer/intracytoplasmic sperm injection embryo transfer, ovarian hyperstimulation syndrome, simultaneous treatment of blood and fluid Ovarian hyperstimulation syndrome (OHSS) is one of the main complications of artificial reproductive technology (ART) with in vitro fertilization embryo transfer (IVF-ET). 1 In clinic, based on the patient's past medical history, clinical manifestations, and additional examinations, OHSS is classified as mild, moderate, or severe. Previous epidemiological investigations have estimated the incidence of moderate and severe OHSS in patients receiving ART with IVF-ET at 3–6% and 0.1–2%, respectively, which leads to negative impact on the daily activities and work lives of patients to varying degrees. The pathogenesis and mechanism of OHSS is very complex. Previous studies have shown that an elevated transient receptor potential melastatin 2 (TRPM2) activity has been found in rat's OHSS-developed ovaries, 2 suggesting the important contributions of ion channels on the pathogenesis of OHSS. Besides, the increased secretions of some cytokines or mediators (eg including vascular endothelial growth factor [VEGF], platelet-derived growth [PDGF], insulin-like growth factor‐1 [IGF‐1]) also been demonstrated to occupy an important role in increased capillary permeability as well as the fluid accumulation in the third space, which may be responsible for the inflammatory response associated with follicular maturation, ovulation, corpus luteum function and embryo implantation. 3,4 Several strategies have been suggested to prevent or relieve the progression of OHSS according to the results obtained from clinical practice and experimental findings, for example, cycle cancel -Abstract Truncated-

[Retrospective Analysis of Treatment for Severe Ovary Hyperstimulation Syndrome Complicated by Pleural Effusion and Ascites].

Therapy Strategy of Severe Ovarian Hyperstimulation Syndrome after IVF-ET

Pregnancy Outcome in Late-Onset Severe OHSS Patients Following Different Ascetic Fluid Drainage and Comparison with the Non-Ohss IVF Patients

Pregnancy Outcomes in Patients with Late-Onset Severe OHSS Following Different Methods of Ascetic Fluid Drainage and a Comparison with Non-Ohss IVF Patients

Effects of Gonadotropin-Releasing Hormone Antagonists on the Expression of Vascular Endothelial Growth Factor and Its Receptors in a Rat Model of Ovarian Hyperstimulation Syndrome.

[Effect of Domestic Highly Purified Urinary Follicle Stimulating Hormone on Outcomes of in Vitro Fertilization-Embryo Transfer in Controlled Ovarian Stimulation].

Controlled Ovarian Stimulation Protocols in Endometriosis Patients: with Antagonist or Agonist?

Clinical Analyses for 93 Cycles of Moderate and Severe Ovarian Hyperstimulation Syndrome

Sequential Combination of Drugs in the Prevention and Treatmentof Moderate and Severe OHSS

Obstetric Outcome Analyses of 132 Cycles in Vitro Fertilized Pregnancies Complicated by Moderate and Severe Ovarian Hyperstimulation Syndrome

Efficacy of Dan'e Fukang Soft Extract in Moderate Ovarian Hyperstimulation Syndrome for Concurrent Treatment of Blood and Fluid Guided by the "Triple Prevention" Principle

Clinical Features of Severe Ovarian Hyperstimulation Syndrome with Hydrothorax

Prevention And Treatment Of Ohss By Administration Of Gnrh Antagonist In The Early Luteal Phase Of Controlled Ovarian Hyperstimulation Cycles

The clinical analysis of 31 cases with moderate or sever ovarian hyperstimulation syndrome.

A Delayed Ovarian Hemorrhage with Severe Ovarian Hyperstimulation Syndrome after Transvaginal Ultrasound-guided Oocyte Retrieval for in Vitro Fertilization-embryo Transfer

Outcome Analysis between IVF-ET Cycle and Whole Embryo Freezing and Thawing Cycle in High-Risk OHSS Patients

Effect of transdermal estrogen for luteal support in ovarian hypersensitivity patients undergoing IVF

Lipid Metabolic Disorders and Ovarian Hyperstimulation Syndrome: A Retrospective Analysis.

Application of oocytes in vitro maturation in preventing ovarian hyperstimulation syndrome.Jin Rentao

Comparison of Hydroxyethyle Starch Versus Human Albumin for Prevention of the Ovarian Hyperstimulation Syndrome

Follicular Aspiration During the Selection Phase Prevents Severe Ovarian Hyperstimulation in Patients with Polycystic Ovary Syndrome Who Are Undergoing in Vitro Fertilization